Skip to content

Clinical study of Ultrasound Measurement of Inferior Vena Cava and Subclavian Vein Correlation Index for Volume Assessment of TURP Patients

Clinical study of Ultrasound Measurement of Inferior Vena Cava and Subclavian Vein Correlation Index for Volume Assessment of TURP Patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080692
Enrollment
Unknown
Registered
2024-02-05
Start date
2024-02-10
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatic hyperplasia

Interventions

Gold Standard:Ultrasound measurement of the cross-sectional area of the inferior vena cava
Index test:Ultrasound measurement of cross-sectional area of subclavian vein

Sponsors

Yan'an Hospital of Kunming City
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Both the study subjects and their families signed the informed consent form for anesthesia. (2) Patients with ASA grade I-III, aged 18-80 years old, who are scheduled to undergo elective surgery for transurethral resection of the prostate. (3) There are no serious comorbidities, and all patients have undergone complete preoperative preparations, including perfect preoperative examinations: blood routine, coagulation function, four pre-transfusion tests, liver and kidney function, electrolytes, blood glucose, blood lipids, chest X-ray, electrocardiogram, etc. (4) The fasting time = 6h, and the fasting time =2h.

Exclusion criteria

Exclusion criteria: (1) Anesthetize patients with ASA class >III (2) Patients with sudden and life-threatening changes in emergency vital signs before surgery; (3) Patients presenting with respiratory distress, increased intra-abdominal pressure, anticipatory airway or mental dysfunction; (4) Patients with autonomic nervous system disorders; (5) Patients with implantable pacemakers or cardioverters; (6) Patients with peripheral vascular disease, severe cardiovascular disease, unstable angina pectoris, or ejection fraction less than 40%; (7) Patients with moderate or above pulmonary artery elevation, pericardial effusion, and portal hypertension; (8) Patients with renal insufficiency, intra-abdominal hypertension or ascites, abdominal obesity that is difficult to observe the inferior vena cava (9) Patients with contraindications to neuraxial anesthesia.

Design outcomes

Primary

MeasureTime frame
Rate of subclavian vein collapse;

Secondary

MeasureTime frame
Inferior vena cava collapse rate;Sensitivity;Specificity;

Countries

China

Contacts

Public ContactXintong Chen

Yan'an Hospital of Kunming City

2513311642@qq.com+86 187 8851 1124

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026